The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
For the Public
Test to Treat
The Test to Treat program is a nationwide initiative to ensure rapid access to no-cost COVID-19 oral antiviral medications that can help reduce risk for hospitalization. At Test to Treat sites, you can get tested for COVID-19 and be assessed by a qualified health care provider. If you test positive and are eligible, you may receive a prescription to take to a designated pharmacy close to the testing location or you may receive medication direct from the Test to Treat site.
Test to Treat
What is Antiviral Medication?
Antiviral medications may help you recover from COVID-19 faster, or prevent you from becoming seriously ill. The medication can boost the immune system, helping it fight off COVID-19 infection. Vaccinations remain the best way to protect a person from COVID, and are a preventative measure to reduce severity of illness and risk of hospitalization or, even, death. Antivirals are prescribed after a person has tested positive for COVID-19 and within 5 days of symptom onset.
Can I get a COVID-19 vaccine if I have had antibody treatment?
If you received monoclonal antibody (mAb) therapy or convalescent plasma after COVID-19 exposure or infection, you do NOT need to delay your COVID-19 vaccination. Getting vaccinated is a priority, and you are able to get vaccinated once your illness is over.